<DOC>
	<DOCNO>NCT01409213</DOCNO>
	<brief_summary>The purpose study collect information risk profile patient type 2 diabetes mellitus , treatment concern meeting guideline treatment diabetic patient type 2 publish Deutsche Diabetes Gesellschaft ( DDG ) October 13 , 2008</brief_summary>
	<brief_title>A Study Current Medical Practice Outcomes Treatment Type 2 Diabetes Mellitus Office Setting ( MK-0431-199 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Newly diagnose Type 2 diabetes treatment metformin individual maximal tolerate dose ( least four week stable dose ) result HbA1c &gt; 6.5 % No contraindication intolerability metformin Currently administer combination therapy treatment Type 2 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>